SQZ Biotechnologies Co 4 SEC Filings

Filed On	Filing
15 Jun 2023	Form 4: Vink Patrick V.j.j., Director Granted 39,875 Stock Option
15 Jun 2023	Form 4: Srivastava Sapna, Director Granted 39,875 Stock Option
15 Jun 2023	Form 4: Schulman Amy W, Director Granted 39,875 Stock Option
15 Jun 2023	Form 4: Schegerin Marc, Director Granted 39,875 Common Stock
15 Jun 2023	Form 4: Jensen Klavs F., Director Granted 39,875 Stock Option
15 Jun 2023	Form 4: Garg Pushkal, Director Granted 39,875 Stock Option
15 Jun 2023	Form 4: Elia Marc, Director Granted 39,875 Stock Option
15 Jun 2023	Form 4: Coulie Bernard, Director Granted 39,875 Stock Option
15 Jun 2023	Form 4: Bolno Paul, Director Granted 39,875 Stock Option
26 Jan 2023	Form 4: Capasso Richard, See Remarks Granted 213,000 Stock Option
26 Jan 2023	Form 4: Warren Marshelle Smith, Chief Medical Officer Granted 261,000 Stock Option
26 Jan 2023	Form 4: Knopf Lawrence J, General Counsel Granted 227,000 Stock Option
26 Jan 2023	Form 4: First David, Chief People Officer Granted 200,000 Stock Option
26 Jan 2023	Form 4: Bernstein Howard Phd Md, Director Granted 830,000 Stock Option
16 Aug 2022	Form 4: Capasso Richard, See Remarks Sold 1,183 shares ($3.93K)
13 Jul 2022	Form 4: Zajic Micah, Chief Financial Officer Granted 10,000 Stock Option
05 Jul 2022	Form 4: Sharei Armon, Director Received 2,436 shares as a grant or award ($6.58K)
05 Jul 2022	Form 4: Knopf Lawrence J, General Counsel Received 1,484 shares as a grant or award ($4.01K)
05 Jul 2022	Form 4: Capasso Richard, See Remarks Received 1,183 shares as a grant or award ($3.2K)
16 Jun 2022	Form 4: Schulman Amy W, Director Granted 20,000 Stock Option

Comments